“ Interestingly, Ingenuity Pathway Analysis causal analysis of baseline gene expression indicated that MAPK target genes were differentially expressed between responsive and non responsive TNBC patient derived samples, such that non responsive cells had gene expression consistent with activation of MAPK signaling pediatric dosage for augmentin ”